Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 98 Total
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.61MEPS (ttm)-12.68
P/E-EPS this Y54.77%
Forward P/E-EPS next Y4.66%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B0.45EPS Q/Q60.48%
Dividend-Sales Q/Q-
Insider Own7.13%Inst Own12.34%
Insider Trans0.00%Inst Trans9.61%
Short Float4.30%EarningsMar 28/a
Analyst Recom1.00Target Price24.50
Avg Volume36.99K52W Range1.95 - 18.95
May-01-24 05:07PM TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire)
Apr-30-24 05:53AM TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
Mar-28-24 10:54PM TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35%
04:05PM TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLSON CAPITAL L P10% OwnerAug 16 '23Sale0.391,0003925,064,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOAug 15 '23Buy0.25600,000150,000814,615Aug 15 08:00 AM
Mikhak ZamanehChief Medical OfficerAug 15 '23Buy0.25120,00030,000135,000Aug 15 08:00 AM
MILLS ROBERT SDirectorAug 15 '23Buy0.2540,00010,00055,980Aug 15 08:00 AM
ROCAMBOLI STEPHENDirectorAug 15 '23Buy0.2520,0005,00036,000Aug 15 08:00 AM
SRG - Seritage Growth Properties - Stock Price Chart
TickerSRG [NYSE]
CompanySeritage Growth Properties
CountryUSA
IndustryREIT - Retail
Market Cap381.44MEPS (ttm)-2.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.25%
P/S14.89EPS next 5Y-
P/B0.70EPS Q/Q68.12%
Dividend-Sales Q/Q886.60%
Insider Own35.67%Inst Own53.90%
Insider Trans-7.34%Inst Trans7.51%
Short Float20.83%EarningsNov 08/a
Analyst Recom1.00Target Price14.00
Avg Volume337.46K52W Range7.07 - 9.92
Seritage Growth Properties operates as a real estate investment trust. The firm engages in the acquisition, ownership, development, redevelopment, management, and leasing of retail properties throughout the United States. Its property portfolio includes mall, shopping centers and freestanding locations. The company was founded on June 3, 2015 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAMPERT EDWARD S10% OwnerApr 01 '24Sale9.7625,655250,28813,484,162Apr 03 09:30 PM
LAMPERT EDWARD S10% OwnerFeb 28 '24Sale9.616,44761,92313,509,817Feb 29 09:30 PM
LAMPERT EDWARD S10% OwnerFeb 27 '24Sale9.6020,694198,68113,516,264Feb 29 09:30 PM
LAMPERT EDWARD S10% OwnerFeb 26 '24Sale9.6045,654438,45613,536,958Feb 26 09:30 PM
LAMPERT EDWARD S10% OwnerFeb 22 '24Sale9.68136,2511,318,43313,582,612Feb 26 09:30 PM
HSCS - Heart Test Laboratories Inc. - Stock Price Chart
TickerHSCS [NASD]
CompanyHeart Test Laboratories Inc.
CountryUSA
IndustryMedical Devices
Market Cap4.63MEPS (ttm)-0.48
P/E-EPS this Y75.00%
Forward P/E-EPS next Y47.50%
PEG-EPS past 5Y-
P/S231.43EPS next 5Y-
P/B0.52EPS Q/Q80.96%
Dividend-Sales Q/Q653.85%
Insider Own16.16%Inst Own2.09%
Insider Trans0.00%Inst Trans4.59%
Short Float1.12%EarningsMar 14/a
Analyst Recom1.00Target Price0.68
Avg Volume1.83M52W Range0.09 - 1.32
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
APDN - Applied Dna Sciences Inc - Stock Price Chart
TickerAPDN [NASD]
CompanyApplied Dna Sciences Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap2.65MEPS (ttm)-17.21
P/E-EPS this Y46.05%
Forward P/E-EPS next Y69.57%
PEG-EPS past 5Y45.52%
P/S0.48EPS next 5Y-
P/B-EPS Q/Q-682.38%
Dividend-Sales Q/Q-78.91%
Insider Own12.32%Inst Own23.02%
Insider Trans0.00%Inst Trans-
Short Float4.18%EarningsMay 10/a
Analyst Recom2.00Target Price7.00
Avg Volume50.06K52W Range3.11 - 37.20
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
AMPX - Amprius Technologies Inc - Stock Price Chart
TickerAMPX [NYSE, RUT]
CompanyAmprius Technologies Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap134.03MEPS (ttm)-0.43
P/E-EPS this Y0.66%
Forward P/E-EPS next Y13.77%
PEG-EPS past 5Y-
P/S14.81EPS next 5Y-
P/B2.11EPS Q/Q-53.63%
Dividend-Sales Q/Q397.98%
Insider Own83.47%Inst Own4.63%
Insider Trans-2.11%Inst Trans-
Short Float11.75%EarningsMay 09/a
Analyst Recom1.29Target Price10.50
Avg Volume620.60K52W Range1.56 - 10.63
Amprius Technologies, Inc. engages in the manufacture and distribution of batteries. Its products are primarily used for existing and emerging aviation applications, including unmanned aerial systems. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bornstein JonathanPresident of Amprius LabApr 12 '24Option Exercise0.051,007,86750,3931,566,797Apr 15 05:53 PM
Bornstein JonathanPresident of Amprius LabApr 02 '24Option Exercise0.05125,9836,299684,913Apr 03 04:13 PM
Bornstein JonathanPresident of Amprius LabApr 02 '24Sale2.38125,983299,613558,930Apr 03 04:13 PM
Bornstein JonathanPresident of Amprius LabMar 06 '24Option Exercise0.0540,2002,01040,200Mar 07 05:36 PM
Bornstein JonathanPresident of Amprius LabMar 06 '24Sale2.7840,200111,5790Mar 07 05:36 PM
LUXH - LuxUrban Hotels Inc - Stock Price Chart
TickerLUXH [NASD]
CompanyLuxUrban Hotels Inc
CountryUSA
IndustryLodging
Market Cap22.74MEPS (ttm)-2.15
P/E-EPS this Y595.59%
Forward P/E1.96EPS next Y311.11%
PEG-EPS past 5Y-227.20%
P/S0.20EPS next 5Y30.00%
P/B-EPS Q/Q-356.48%
Dividend-Sales Q/Q112.47%
Insider Own75.61%Inst Own15.28%
Insider Trans-0.30%Inst Trans157.88%
Short Float27.63%EarningsMay 13/a
Analyst Recom1.67Target Price5.00
Avg Volume457.46K52W Range0.62 - 6.88
LuxUrban Hotels Inc. engages in the acquisition and management of hotel units. The company was founded on December 13, 2019 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferdinand BrianChairman & Co-CEODec 13 '23Buy4.5625,000114,050225,825Dec 14 08:30 AM
Ferdinand BrianChairman & Co-CEODec 01 '23Sale4.4514,21963,27515,347,917Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 30 '23Sale4.4662,000276,52015,362,136Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 22 '23Sale5.216,55634,15715,424,136Nov 24 05:13 PM
Ferdinand BrianChairman & Co-CEONov 21 '23Sale5.1038,277195,21315,430,692Nov 24 05:13 PM
TBIO - Telesis Bio Inc - Stock Price Chart
TickerTBIO [NASD]
CompanyTelesis Bio Inc
CountryUSA
IndustryMedical Devices
Market Cap6.93MEPS (ttm)-28.31
P/E-EPS this Y48.61%
Forward P/E-EPS next Y29.33%
PEG-EPS past 5Y-55.07%
P/S0.28EPS next 5Y-
P/B-EPS Q/Q18.20%
Dividend-Sales Q/Q-45.54%
Insider Own72.87%Inst Own4.30%
Insider Trans0.00%Inst Trans-
Short Float0.79%EarningsMay 09/a
Analyst Recom1.67Target Price72.00
Avg Volume49.17K52W Range4.85 - 52.56
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
BNED - Barnes & Noble Education Inc - Stock Price Chart
TickerBNED [NYSE]
CompanyBarnes & Noble Education Inc
CountryUSA
IndustrySpecialty Retail
Market Cap9.85MEPS (ttm)-1.56
P/E-EPS this Y57.12%
Forward P/E-EPS next Y47.14%
PEG-EPS past 5Y18.50%
P/S0.01EPS next 5Y20.00%
P/B0.10EPS Q/Q61.93%
Dividend-Sales Q/Q2.15%
Insider Own28.68%Inst Own32.49%
Insider Trans0.00%Inst Trans-3.22%
Short Float5.32%EarningsMar 12/a
Analyst Recom3.00Target Price0.75
Avg Volume1.44M52W Range0.18 - 2.26
Barnes and Noble Education, Inc. engages in the management and operation of bookstore chains in universities. It operates through the following segments: Retail, Wholesale, and Digital Student Solutions (DSS). The Retail segment operates physical and virtual campus bookstores. The Wholesale segment sells hardware and software that provides inventory management and point-of-sale solutions to college bookstores. The DSS segment includes direct-to-student product and service offerings to assist students to study more effectively and improve academic performance. The company was founded by Leonard Riggio in 1965 and is headquartered in Basking Ridge, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAR JONATHANEVP, RetailSep 22 '23Option Exercise0.0079,2690186,682Sep 26 04:43 PM
MILLER MICHAEL CONNOLLYCLO, EVP, Corp Aff & SecretarySep 22 '23Option Exercise0.0060,9760210,482Sep 26 04:41 PM
Paul SeemaSVP, Chief Accounting OfficerSep 22 '23Option Exercise0.0016,9380137,597Sep 26 04:42 PM
HUSEBY MICHAELCEOSep 22 '23Option Exercise0.00223,57801,199,988Sep 26 04:40 PM
HCTI - Healthcare Triangle Inc - Stock Price Chart
TickerHCTI [NASD]
CompanyHealthcare Triangle Inc
CountryUSA
IndustryHealth Information Services
Market Cap4.08MEPS (ttm)-2.90
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.12EPS next 5Y-
P/B7.02EPS Q/Q-6.14%
Dividend-Sales Q/Q-37.48%
Insider Own57.13%Inst Own0.31%
Insider Trans0.00%Inst Trans-
Short Float3.39%EarningsMar 15/b
Analyst Recom1.00Target Price15.00
Avg Volume529.51K52W Range0.99 - 10.89
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded on October 29, 2019 and is headquartered in Pleasanton, CA.
ASNS - Actelis Networks Inc - Stock Price Chart
TickerASNS [NASD]
CompanyActelis Networks Inc
CountryUSA
IndustryCommunication Equipment
Market Cap1.63MEPS (ttm)-2.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.29EPS next 5Y-
P/B7.09EPS Q/Q52.85%
Dividend-Sales Q/Q-59.87%
Insider Own7.64%Inst Own11.47%
Insider Trans-0.09%Inst Trans-57.30%
Short Float0.15%EarningsMar 26/a
Analyst Recom-Target Price-
Avg Volume84.85K52W Range0.53 - 4.56
Actelis Networks, Inc. is a networking solutions company that implements communication for IoT projects. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create quick-to-deploy network. The firm develops broadband solutions for telecom service providers, enterprises and municipalities. It is accelerating broadband services to businesses and residential subscribers through Broadband Accelerator (BBA), EFMplus, Dynamic Rate Boost (DRB) and Dynamic Spectral Shaping (DSS). The company was founded by Yuval Baron, Tuvia Barlev and Kamran Elahian in 1998 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winkler-Solomon MichalVice President MarketingSep 29 '23Sale1.112052284,266Dec 12 04:25 PM
Barlev TuviaCEO and Chairman of the BoardMay 17 '23Sale3.322,1076,995163,598May 18 04:05 PM
Niv IsraelDirectorMay 17 '23Sale3.324221,40167,218May 18 04:05 PM
12345678910